Literature DB >> 18761660

Linkage and association study of late-onset Alzheimer disease families linked to 9p21.3.

S Züchner1, J R Gilbert, E R Martin, C R Leon-Guerrero, P-T Xu, C Browning, P G Bronson, P Whitehead, D E Schmechel, J L Haines, M A Pericak-Vance.   

Abstract

A chromosomal locus for late-onset Alzheimer disease (LOAD) has previously been mapped to 9p21.3. The most significant results were reported in a sample of autopsy-confirmed families. Linkage to this locus has been independently confirmed in AD families from a consanguineous Israeli-Arab community. In the present study we analyzed an expanded clinical sample of 674 late-onset AD families, independently ascertained by three different consortia. Sample subsets were stratified by site and autopsy-confirmation. Linkage analysis of a dense array of SNPs across the chromosomal locus revealed the most significant results in the 166 autopsy-confirmed families of the NIMH sample. Peak HLOD scores of 4.95 at D9S741 and 2.81 at the nearby SNP rs2772677 were obtained in a dominant model. The linked region included the cyclin-dependent kinase inhibitor 2A gene (CDKN2A), which has been suggested as an AD candidate gene. By re-sequencing all exons in the vicinity of CDKN2A in 48 AD cases, we identified and genotyped four novel SNPs, including a non-synonymous, a synonymous, and two variations located in untranslated RNA sequences. Family-based allelic and genotypic association analysis yielded significant results in CDKN2A (rs11515: PDT p = 0.003, genotype-PDT p = 0.014). We conclude that CDKN2A is a promising new candidate gene potentially contributing to AD susceptibility on chromosome 9p.

Entities:  

Mesh:

Year:  2008        PMID: 18761660      PMCID: PMC2821735          DOI: 10.1111/j.1469-1809.2008.00474.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  26 in total

1.  GOLD--graphical overview of linkage disequilibrium.

Authors:  G R Abecasis; W O Cookson
Journal:  Bioinformatics       Date:  2000-02       Impact factor: 6.937

2.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium.

Authors:  Christopher S Carlson; Michael A Eberle; Mark J Rieder; Qian Yi; Leonid Kruglyak; Deborah A Nickerson
Journal:  Am J Hum Genet       Date:  2003-12-15       Impact factor: 11.025

3.  Results of a high-resolution genome screen of 437 Alzheimer's disease families.

Authors:  Deborah Blacker; Lars Bertram; Aleister J Saunders; Thomas J Moscarillo; Marilyn S Albert; Howard Wiener; Rodney T Perry; Julianne S Collins; Lindy E Harrell; Rodney C P Go; Amy Mahoney; Terri Beaty; M Danielle Fallin; Dimitrios Avramopoulos; Gary A Chase; Marshal F Folstein; Melvin G McInnis; Susan S Bassett; Kimberly J Doheny; Elizabeth W Pugh; Rudolph E Tanzi
Journal:  Hum Mol Genet       Date:  2003-01-01       Impact factor: 6.150

4.  Genotype-based association test for general pedigrees: the genotype-PDT.

Authors:  E R Martin; M P Bass; J R Gilbert; M A Pericak-Vance; E R Hauser
Journal:  Genet Epidemiol       Date:  2003-11       Impact factor: 2.135

5.  Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a.

Authors:  H J Lüth; M Holzer; H J Gertz; T Arendt
Journal:  Brain Res       Date:  2000-01-03       Impact factor: 3.252

6.  Identification of novel genes in late-onset Alzheimer's disease.

Authors:  M A Pericak-Vance; J Grubber; L R Bailey; D Hedges; S West; L Santoro; B Kemmerer; J L Hall; A M Saunders; A D Roses; G W Small; W K Scott; P M Conneally; J M Vance; J L Haines
Journal:  Exp Gerontol       Date:  2000-12       Impact factor: 4.032

7.  Full genome screen for Alzheimer disease: stage II analysis.

Authors:  Amanda Myers; Fabienne Wavrant De-Vrieze; Peter Holmans; Marian Hamshere; Richard Crook; Danielle Compton; Helen Marshall; David Meyer; Shantia Shears; Jeremy Booth; Dzanan Ramic; Heather Knowles; John C Morris; Nigel Williams; Nadine Norton; Richard Abraham; Pat Kehoe; Hywel Williams; Varuni Rudrasingham; Francis Rice; Peter Giles; Nigel Tunstall; Lesley Jones; Simon Lovestone; Julie Williams; Michael J Owen; John Hardy; Alison Goate
Journal:  Am J Med Genet       Date:  2002-03-08

8.  Cyclin C expression is involved in the pathogenesis of Alzheimer's disease.

Authors:  Uwe Ueberham; Annett Hessel; Thomas Arendt
Journal:  Neurobiol Aging       Date:  2003 May-Jun       Impact factor: 4.673

9.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08

10.  Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community.

Authors:  Lindsay A Farrer; Abdalla Bowirrat; Robert P Friedland; Kristin Waraska; Amos D Korczyn; Clinton T Baldwin
Journal:  Hum Mol Genet       Date:  2003-02-15       Impact factor: 6.150

View more
  20 in total

1.  Cell-dependent kinase inhibitor 2A and 2B genetic variability in patients with Alzheimer's disease.

Authors:  Francesca Cortini; Chiara Fenoglio; Eliana Venturelli; Chiara Villa; Francesca Clerici; Maria Serpente; Claudia Cantoni; Giorgio Fumagalli; Claudio Mariani; Nereo Bresolin; Elio Scarpini; Daniela Galimberti
Journal:  J Neurol       Date:  2010-11-11       Impact factor: 4.849

2.  Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP data.

Authors:  Richard Sherva; Clinton T Baldwin; Rivka Inzelberg; Badri Vardarajan; L Adrienne Cupples; Kathryn Lunetta; Abdalla Bowirrat; Adam Naj; Margaret Pericak-Vance; Robert P Friedland; Lindsay A Farrer
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 3.  Cellular senescence: from physiology to pathology.

Authors:  Daniel Muñoz-Espín; Manuel Serrano
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07       Impact factor: 94.444

Review 4.  Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health.

Authors:  Nikolay Popov; Jesús Gil
Journal:  Epigenetics       Date:  2010-11-01       Impact factor: 4.528

5.  Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression.

Authors:  Michael S Cunnington; Mauro Santibanez Koref; Bongani M Mayosi; John Burn; Bernard Keavney
Journal:  PLoS Genet       Date:  2010-04-08       Impact factor: 5.917

Review 6.  Noncoding RNAs in neurodegeneration.

Authors:  Evgenia Salta; Bart De Strooper
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

Review 7.  Long noncoding RNAs in psychiatric disorders.

Authors:  Lingjun Zuo; Yunlong Tan; Zhiren Wang; Ke-Sheng Wang; Xiangyang Zhang; Xiangning Chen; Chiang-Shan R Li; Tong Wang; Xingguang Luo
Journal:  Psychiatr Genet       Date:  2016-06       Impact factor: 2.458

Review 8.  Review: a meta-analysis of GWAS and age-associated diseases.

Authors:  William R Jeck; Alex P Siebold; Norman E Sharpless
Journal:  Aging Cell       Date:  2012-08-30       Impact factor: 9.304

9.  Genome-wide association studies of coronary artery disease and heart failure: where are we going?

Authors:  Gerald W Dorn; Sharon Cresci
Journal:  Pharmacogenomics       Date:  2009-02       Impact factor: 2.533

Review 10.  Long non-coding RNAs: novel targets for nervous system disease diagnosis and therapy.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.